Navigation Links
QB3, Deloitte collaborate to drive California bioscience innovation

The California Institute for Quantitative Biosciences (QB3) has entered into a collaboration with Deloitte to help the institute in its efforts to convert bioscience innovation into a driver for jobs, companies and improved health in California.

Deloitte, which provides consulting, audit, tax and financial advisory services, will provide its services at no cost to help QB3 develop an "innovation ecosystem," bringing together the four pillars of the bioscience community academic research, government, industry and investors to work in unison toward a common vision of economic growth and better health.

"The California economy and life sciences industry seem to be caught in an almost desperate search for creative new approaches," said QB3 Director Regis Kelly, PhD. "We see the 'innovation ecosystem' project as the start of an ongoing effort with Deloitte to generate the kind of creative solutions that are needed now and into the future."

The collaboration includes a commitment from Deloitte's life science practice, which started working with QB3 in December 2010 to assess how California compares to other states in fostering bioscience innovation. Deloitte will continue to contribute its organizational experience in the life sciences to offer perspectives on operations and business models from other states, as well as insights on collaborations and federal policy. This, in turn, will help QB3 in its efforts to generate new approaches to working within the rapidly changing biotech industry.

"Our collaboration with QB3 is one of the largest life science initiatives and investments for Deloitte's life sciences practice," said Christie Smith, PhD, principal, Deloitte Consulting LLP and Northern Pacific sector leader for life sciences. "This opportunity allows Deloitte to bring its capabilities in audit, tax, financial advisory services and consulting to aid QB3 in achieving its mission."

The services will include strategic analysis and planning, as well as project management, to extend QB3's relationships with government, universities, investors and bioscience companies in an effort to both motivate investments in innovation and help move ideas from lab to market more quickly. It also will include third-party feedback on QB3's impact and success over the last decade in creating jobs, supporting entrepreneurs and growing California's bioeconomy.

The team's deliberate focus on the four stakeholder communities is what makes this initiative so unusual, Kelly said, but also could be the root of its success in helping to "unclog the pipeline" that leads from scientific discoveries to real-world benefits for patients.

It represents a challenge, as well, in fostering a united mission among large and small companies, sophisticated investors, top-ranked researchers and entrepreneurs, according to Matthew K. Hudes, Deloitte's U.S. leader for biotechnology.

"The problems in life sciences cannot be solved without the key players working together, not only from the private and public sector, but also from university researchers who are the starting point for innovative breakthroughs," Hudes said. "Our goal is to develop a model for an innovation ecosystem that enables those breakthroughs to improve human health worldwide."

In a separate initiative, Deloitte and QB3 will launch a program of bioscience industry awards and speaker forums to recognize scientific innovators and entrepreneurs, and provide a platform for networking and learning.


Contact: Kristen Bole
University of California - San Francisco

Related medicine news :

1. Hope Phones, IntraHealth and FrontlineSMS:Medic Collaborate on Phone Donation Campaign to Support Health Workers in Africa
2. The Advisory Board Company and HIMSS Analytics to Collaborate to Solve Health Care IT Challenges
3. Philips Collaborates with Microsoft to Enhance Healthcare Efficiencies and Productivity
4. FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs
5. Eisner USA, LLC Collaborates with Surgical Review Corp to Provide Innovative Bariatric Devices to Bariatric Surgery Center of Excellence (BSCOE) Participants
6. Doctors must collaborate so that patients get full benefit of tamoxifen treatment
7. PeopleStreme Collaborates with SkillSoft for Learning Management Content
8. BCS Global and Iformata Sign Agreement to Collaborate on the PSVN Initiative to Deliver B2B Video Communications
9. Two Hand Therapy Organizations Collaborate on Jam-Packed Educational Weekend
10. Carefx to Collaborate with the Cleveland Clinic to Commercialize CCF Business Intelligence Solution
11. Elsevier and InfoDesk collaborate to co-develop federated drug pipeline intelligence solution
Post Your Comments:
(Date:11/25/2015)... OH (PRWEB) , ... November 25, 2015 , ... Dental ... implants in Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced Implant ... this year in Cleveland, OH. , As the co-founders of Advanced Implant Mentoring ...
(Date:11/25/2015)... ... ... The McHenry County law firm of Botto Gilbert Lancaster, PC ... Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant David Adcock ... , According to court documents, Adcock testified that on May 10, 2010 he sat ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - ... surgeon specializing in both surgical and non-surgical treatments, announced the expansion of his ... Facial Plastic Surgery. , Highly trained and nationally recognized for his natural ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... ST. LOUIS, Missouri (PRWEB) , ... November 25, ... ... with Project HEAL, will provide scholarships for people struggling with eating disorders as ... Proceeds from the second annual event, held at Fox Run Golf Club ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... November 25, 2015 Kitov Pharma ... (TASE: KTOV), a biopharmaceutical company focused on the development ... clinical conditions, today announced the closing of its previously ... ( ADSs ), each representing 20 ordinary shares of ... ADSs. The ADSs and warrants were issued in a ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Today AVACEN Medical announced the issue of ... of Thermal Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry ... AVACEN Treatment Method. Photo - ... ... ...
(Date:11/25/2015)... Nov. 25, 2015 USP 800 applies ... preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician ... The chapter also covers all entities which store, ... hospitals, other healthcare institutions, patient treatment clinics, physicians, ... --> --> What is the ...
Breaking Medicine Technology: